Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan-Dec:23:2515690X18774273.
doi: 10.1177/2515690X18774273.

Ginger Extract and [6]-Gingerol Inhibit Contraction of Rat Entire Small Intestine

Affiliations

Ginger Extract and [6]-Gingerol Inhibit Contraction of Rat Entire Small Intestine

Usana Chatturong et al. J Evid Based Integr Med. 2018 Jan-Dec.

Abstract

This study aims to investigate the effect of oral administration and the direct action of ginger extract or [6]-gingerol on small intestinal contractility. The direct effect of 10 minutes preincubation of ginger ethanolic extract (10, 100 and 300 μg/mL) or [6]-gingerol (1, 30, and 100 μM) on 0.01 to 30 μM ACh-induced contractions of all parts of the small intestine isolated from normal rats was investigated using the organ bath technique. For in vivo study, the rats were orally administered with extract (10, 20, and 100 mg/kg/d) or [6]-gingerol (2 mg/kg/d) for 7 days, followed by determining the contractile responses to ACh of rat isolated duodenum, jejunum, and ileum and their histology were assessed. Direct application of the extract or [6]-gingerol attenuated ACh-induced contractions in each small intestinal segment, Emax was reduced by 40% to 80%, while EC50 increased 3- to 8-fold from control. Similarly, in the in vivo study ACh-induced contractions were reduced in all parts of the small intestine isolated from rats orally treated with ginger extract (20 and 100 mg/kg/d) or [6]-gingerol (2 mg/kg/d). Emax decreased 15% to 30%, while EC50 increased 1- to 3-fold compared to control. No discernable changes in the histology of intestinal segments were detectable. Thus, the results support the clinical application of ginger for disorders of gastrointestinal motility.

Keywords: [6]-gingerol; contraction; ginger; small intestine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
HPLC chromatogram of active compounds in the ginger extract. Column: Luna C18 4.6 × 150 mm; Mobile phase: water/acetonitrile (gradient).
Figure 2.
Figure 2.
Inhibitory effect of ginger extract or [6]-gingerol on spontaneous contraction of rat isolated duodenum, jejunum, and ileum. (A) Representative tracing of the duodenum, jejunum, and ileum spontaneous contraction before and after 10 minutes preincubation with DMSO, 300 μg/mL ginger extract, or 100 μM [6]-gingerol. (B) Contraction expressed as percentage to high K+ (80 mM) solution-induced maximum contraction of isolated duodenum, jejunum, and ileum before (control) and after incubation with DMSO, 10 to 300 μg/mL ginger extract, or 1 to 100 μM [6]-gingerol. All data were expressed as means ± SEM (n = 5). ***P < .001 versus the control or DMSO; ††† P < .001 versus the 10 μg/mL ginger extract; ‡‡‡ P < .001 versus the 1 μM [6]-gingerol.
Figure 3.
Figure 3.
Inhibitory effect of ginger extract (A) and [6]-gingerol (B) on cumulative ACh-induced contractions of rat isolated duodenum, jejunum, and ileum. Small intestinal segments were preincubated with either DMSO, 10 to 300 μg/mL ginger extract, or 1 to 100 μM [6]-gingerol for 10 minutes, and then concentration-contraction responses to ACh were obtained. Contractions were expressed as percentage of 80 mM K+ solution-induced maximum response. All data were expressed as means ± SEM (n = 5-6). ***P < .001 versus the control; ### P < .001 versus the DMSO; ††† P < .001 versus the 10 μg/mL ginger extract; ‡‡‡ P < .001 versus the 1 μM [6]-gingerol.
Figure 4.
Figure 4.
Concentration response curves of ACh-induced contraction in duodenum (A), jejunum (B), and ileum (C) isolated from rats orally administered with 10 to 100 mg/kg/d ginger extract or 2 mg/kg/d [6]-gingerol for 7 days. Values are means ± SEM (n = 6). ***P < .001 versus the control; # P < .05, ### P < .001 versus the 10 mg/kg ginger extract group.
Figure 5.
Figure 5.
(A) Typical histological cross-section images of rat duodenum, jejunum, and ileum isolated from rats orally administered with PG (control), 10 to 100 mg/kg/d ginger extract, or 2 mg/kg/d [6]-gingerol for 7 days (H&E; ×100 original magnification, insets ×400 original magnification of the area indicated by black arrows). (B) The lengths of the villi and crypts, and thicknesses of the circular and longitudinal muscle layers of duodenum, jejunum, or ileum. Values are means ± SEM (n = 5).

Similar articles

Cited by

References

    1. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46:409–420. - PubMed
    1. Tohma H, Gülçin İ, Bursal E, Gören AC, Alwasel SH, Köksal E. Antioxidant activity and phenolic compounds of ginger (Zingiber officinale Rosc) determined by HPLC-MS/MS. J Food Meas Charact. 2017;11:556–566.
    1. Kim HS, Park HD. Ginger extract inhibits biofilm formation by Pseudomonas aeruginosa PA14. PLoS One. 2013;8:e76106. - PMC - PubMed
    1. Ryan JL, Heckler CE, Roscoe JA, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012;20:1479–1489. - PMC - PubMed
    1. Chen JC, Huang LJ, Wu SL, Kuo SC, Ho TY, Hsiang CY. Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice. J Agric Food Chem. 2007;55:8390–8397. - PubMed

LinkOut - more resources